Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Introduction

Anandamide (AEA), an endocannabinoid, has demonstrated analgesic and anti-inflammatory properties in various experimental models. However, the mechanisms underlying its role in neuropathic pain and inflammation remain unclear.

Methods

Carrageenan-induced inflammation and Chronic Constriction Injury (CCI) were used to model inflammatory and neuropathic pain in Wistar rats. Behavioral tests (., paw edema, mechanical and thermal hyperalgesia), hematological and biochemical analyses, and molecular studies (mRNA expression of AEA pathway enzymes) were conducted to evaluate AEA’s therapeutic potential.

Results

Anandamide significantly reduced paw edema and alleviated pain behaviors in CCI rats in a dose-dependent manner. It normalized hematological and biochemical markers and decreased levels of oxidative stress indicators (MDA, nitrite). mRNA analysis revealed upregulation of AEA degradation enzymes following CCI, indicating disrupted endocannabinoid signaling.

Discussion

AEA’s analgesic and anti-inflammatory actions appear to be mediated through CB1 receptor activation and modulation of ATP-sensitive potassium channels. The observed improvements in biochemical and behavioral markers suggest its efficacy in modulating neuroinflammation and neuropathic pain.

Conclusion

Anandamide demonstrates significant potential as a therapeutic agent in managing neuropathic and inflammatory pain. Further studies are warranted to elucidate its mechanisms and optimize its clinical applicability.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026391315250822063941
2025-10-16
2026-03-02

  • From This Site

    /content/journals/cnr/10.2174/0115672026391315250822063941
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MitchellS.W. Injuries of nerves and their consequences.Arch. Neurol.1970221909410.1001/archneur.1970.00480190094016 4912198
     [Google Scholar]
  2. DworkinR.H. PanaritesC.J. ArmstrongE.P. MaloneD.C. PhamS.V. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?Pain2012153486987510.1016/j.pain.2012.01.015 22356792
     [Google Scholar]
  3. MitchellSW Injuries of nerves and their consequences.Dover citations19652
     [Google Scholar]
  4. DothA.H. HanssonP.T. JensenM.P. TaylorR.S. The burden of neuropathic pain: A systematic review and meta-analysis of health utilities.Pain2010149233834410.1016/j.pain.2010.02.034 20227832
     [Google Scholar]
  5. AttalN. Lanteri-MinetM. LaurentB. FermanianJ. BouhassiraD. The specific disease burden of neuropathic pain: Results of a French nationwide survey.Pain2011152122836284310.1016/j.pain.2011.09.014 22019149
     [Google Scholar]
  6. LangleyP.C. Van LitsenburgC. CappelleriJ.C. CarrollD. The burden associated with neuropathic pain in Western Europe.J. Med. Econ.2013161859510.3111/13696998.2012.729548 22970839
     [Google Scholar]
  7. CollocaL. LudmanT. BouhassiraD. Neuropathic pain.Nat. Rev. Dis. Primers2017311700210.1038/nrdp.2017.2 28205574
     [Google Scholar]
  8. JensenT.S. BaronR. HaanpääM. A new definition of neuropathic pain.Pain2011152102204220510.1016/j.pain.2011.06.017 21764514
     [Google Scholar]
  9. WoolfC.J. Pain: Moving from symptom control toward mechanism-specific pharmacologic management.Ann. Intern. Med.2004140644145110.7326/0003‑4819‑140‑8‑200404200‑00010 15023710
     [Google Scholar]
  10. TorranceN. SmithB.H. WatsonM.C. BennettM.I. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin.Fam. Pract.200724548148510.1093/fampra/cmm042 17670804
     [Google Scholar]
  11. BennettM.I. SmithB.H. TorranceN. LeeA.J. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians.Pain2006122328929410.1016/j.pain.2006.02.002 16540249
     [Google Scholar]
  12. TorranceN. FergusonJ.A. AfolabiE. Neuropathic pain in the community: More under-treated than refractory?Pain2013154569069910.1016/j.pain.2012.12.022 23485369
     [Google Scholar]
  13. WoodG.W. The psychology of wellbeing.Routledge202010.4324/9781003021254
     [Google Scholar]
  14. CianfriniL.R. DoleysD.M. Psychological assessment in the context of head and facial pain.In: Diagnosis and Management of Head and Face Pain.Springer2018699310.1007/978‑3‑319‑90999‑8_7
     [Google Scholar]
  15. ForouzanfarF. Pourbagher-ShahriA.M. GhazaviH. Evaluation of antiarthritic and antinociceptive effects of cedrol in a rat model of arthritis.Oxid. Med. Cell. Longev.20222022494396510.1155/2022/4943965 35509836 PMC9060983
     [Google Scholar]
  16. LoeserJ.D. TreedeR.D. The Kyoto protocol of IASP basic pain terminology.Pain2008137347347710.1016/j.pain.2008.04.025 18583048
     [Google Scholar]
  17. FonsecaB.M. CostaM.A. AlmadaM. Correia-da-SilvaG. TeixeiraN.A. Endogenous cannabinoids revisited: A biochemistry perspective.Prostaglandins Other Lipid Mediat.2013102-103133010.1016/j.prostaglandins.2013.02.002 23474290
     [Google Scholar]
  18. MakriyannisA. NikasS. ThakurG. PavlopoulosS. Cannabinoid receptors as therapeutic targets.Curr. Pharm. Des.200612141751176910.2174/138161206776873743 16712486
     [Google Scholar]
  19. KatonaI. FreundT.F. Multiple functions of endocannabinoid signaling in the brain.Annu. Rev. Neurosci.201235152955810.1146/annurev‑neuro‑062111‑150420 22524785
     [Google Scholar]
  20. ACTS, Rules and guidelines: Committee for the purpose of control and supervision of experiments on animals.2018Available from: https://cpcsea.nic.in/Content/54_1_ACTS,RULESANDGUIDELINES.aspx.
  21. WinterC.A. RisleyE.A. NussG.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.Exp. Biol. Med. (Maywood)1962111354454710.3181/00379727‑111‑27849 14001233
     [Google Scholar]
  22. LanhersM.C. FleurentinJ. MortierF. VincheA. YounosC. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens.Planta Med.199258211712310.1055/s‑2006‑961411 1529021
     [Google Scholar]
  23. MorrisC.J. Carrageenan-induced paw edema in the rat and mouse.Inflamm Protoc200311512110.1385/1‑59259‑374‑7:115
     [Google Scholar]
  24. BennettG.J. XieY.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.Pain19883318710710.1016/0304‑3959(88)90209‑6 2837713
     [Google Scholar]
  25. JaggiA.S. SinghN. Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats.Eur. J. Pharmacol.20106481-310210910.1016/j.ejphar.2010.08.050 20846523
     [Google Scholar]
  26. MuthuramanA. JaggiA.S. SinghN. SinghD. Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats.Eur. J. Pharmacol.20085871-310411110.1016/j.ejphar.2008.03.042 18486127
     [Google Scholar]
  27. ForouzanfarF. TanhaN.K. Pourbagher-ShahriA.M. mahdianpour S, Esmaeili M, Ghazavi H. Synergistic effect of ellagic acid and gabapentin in a rat model of neuropathic pain.Metab. Brain Dis.20233841421143210.1007/s11011‑023‑01190‑x 36811684
     [Google Scholar]
  28. NeesT.A. Tappe-TheodorA. SliwinskiC. Early-onset treadmill training reduces mechanical allodynia and modulates calcitonin gene-related peptide fiber density in lamina III/IV in a mouse model of spinal cord contusion injury.Pain2016157368769710.1097/j.pain.0000000000000422 26588690
     [Google Scholar]
  29. Di RosaM. GiroudJ.P. WilloughbyD.A. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.J. Pathol.19711041152910.1002/path.1711040103 4398139
     [Google Scholar]
  30. FlattersS.J.L. BennettG.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.Pain2004109115016110.1016/j.pain.2004.01.029 15082137
     [Google Scholar]
  31. ErichsenH.K. Blackburn-MunroG. Pharmacological characterisation of the spared nerve injury model of neuropathic pain.Pain200298115116110.1016/S0304‑3959(02)00039‑8 12098627
     [Google Scholar]
  32. JainV. JaggiA.S. SinghN. Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats.Pharmacol. Res.200959638539210.1016/j.phrs.2009.02.001 19429470
     [Google Scholar]
  33. GracelyR.H. LynchS.A. BennettG.J. Painful neuropathy: Altered central processing maintained dynamically by peripheral input.Pain199251217519410.1016/0304‑3959(92)90259‑E 1484715
     [Google Scholar]
  34. OchoaJ.L. YarnitskyD. Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes.Ann. Neurol.199333546547210.1002/ana.410330509 8388678
     [Google Scholar]
  35. ThibaultK. ElisabethB. SophieD. ClaudeF.Z.M. BernardR. BernardC. Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine.Eur. J. Pharmacol.20086001-3717710.1016/j.ejphar.2008.10.004 18938155
     [Google Scholar]
  36. Weissman-FogelI. DashkovskyA. RogowskiZ. YarnitskyD. Vagal damage enhances polyneuropathy pain: Additive effect of two algogenic mechanisms.Pain2008138115316210.1016/j.pain.2007.11.017 18207324
     [Google Scholar]
  37. JoE.J. BaeE. YoonJ.H. KimJ.Y. HanJ.S. Comparison of murine retroorbital plexus and facial vein blood collection to mitigate animal ethics issues.Lab. Anim. Res.20213711210.1186/s42826‑021‑00090‑4 33958002
     [Google Scholar]
  38. KratzD. Wilken-SchmitzA. SensA. Post-mortem changes of prostanoid concentrations in tissues of mice: Impact of fast cervical dislocation and dissection delay.Prostaglandins Other Lipid Mediat.202216210666010.1016/j.prostaglandins.2022.106660 35714920
     [Google Scholar]
  39. JahangirT. SultanaS. Modulatory effects of Pluchea lanceolata against chemically induced oxidative damage, hyperproliferation and two-stage renal carcinogenesis in Wistar rats.Mol. Cell. Biochem.20062911-217518510.1007/s11010‑006‑9213‑8 16767495
     [Google Scholar]
  40. WillsE.D. Mechanisms of lipid peroxide formation in animal tissues.Biochem. J.196699366767610.1042/bj0990667 5964963
     [Google Scholar]
  41. EllmanG.L. Tissue sulfhydryl groups.Arch. Biochem. Biophys.1959821707710.1016/0003‑9861(59)90090‑6 13650640
     [Google Scholar]
  42. GreenL.C. WagnerD.A. GlogowskiJ. SkipperP.L. WishnokJ.S. TannenbaumS.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.Anal. Biochem.1982126113113810.1016/0003‑2697(82)90118‑X 7181105
     [Google Scholar]
  43. CullingC.F.A. Handbook of Histopathological and Histochemical Techniques.3rd edOxford, UKButterworth-Heinemann19742961
     [Google Scholar]
  44. AttalN. JazatF. KayserV. GuilbaudG. Further evidence for ‘pain-related’ behaviours in a model of unilateral peripheral mononeuropathy.Pain199041223525110.1016/0304‑3959(90)90022‑6 2164179
     [Google Scholar]
  45. HuB. DoodsH. TreedeR.D. CeciA. Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833.Pain2009143320621210.1016/j.pain.2009.02.018 19345493
     [Google Scholar]
  46. JesseC.R. WilhelmE.A. NogueiraC.W. Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: A comparison with fluoxetine, amitriptyline, and bupropion.Psychopharmacology (Berl.)2010212451352210.1007/s00213‑010‑1977‑6 20689938
     [Google Scholar]
  47. UrbanR. ScherrerG. GouldingE.H. TecottL.H. BasbaumA.I. Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity.Pain20111525990100010.1016/j.pain.2010.12.003 21256675
     [Google Scholar]
  48. MyersR.R. YamamotoT. YakshT.L. PowellH.C. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia.Anesthesiology199378230831610.1097/00000542‑199302000‑00015 8439027
     [Google Scholar]
  49. GraceP.M. HutchinsonM.R. ManavisJ. SomogyiA.A. RolanP.E. A novel animal model of graded neuropathic pain: Utility to investigate mechanisms of population heterogeneity.J. Neurosci. Methods20101931475310.1016/j.jneumeth.2010.08.025 20817038
     [Google Scholar]
  50. KajanderK.C. PollockC.H. BergH. Evaluation of hindpaw position in rats during chronic constriction injury (CCI) produced with different suture materials.Somatosens. Mot. Res.19961329510110.3109/08990229609051397 8844958
     [Google Scholar]
  51. XuJ. PollockC.H. KajanderK.C. Chromic gut suture reduces calcitonin-gene-related peptide and substance P levels in the spinal cord following chronic constriction injury in the rat.Pain199664350350910.1016/0304‑3959(95)00172‑7 8783315
     [Google Scholar]
  52. SommerC. SchäfersM. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: Differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity.Brain Res.19987841-215416210.1016/s0006‑8993(97)01327‑9 9518588
     [Google Scholar]
  53. MogilJ.S. DavisK.D. DerbyshireS.W. The necessity of animal models in pain research.Pain20101511121710.1016/j.pain.2010.07.015 20696526
     [Google Scholar]
  54. Ho KimS. Mo ChungJ. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.Pain199250335536310.1016/0304‑3959(92)90041‑9 1333581
     [Google Scholar]
  55. RakhshandehH. GhorbanzadehA. NegahS.S. AkaberiM. RashidiR. ForouzanfarF. Pain-relieving effects of Lawsonia inermis on neuropathic pain induced by chronic constriction injury.Metab. Brain Dis.20213671709171610.1007/s11011‑021‑00773‑w 34169409
     [Google Scholar]
  56. ChanC.C. BoyceS. BrideauC. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.J. Pharmacol. Exp. Ther.199527431531153710.1016/S0022‑3565(25)10713‑1 7562530
     [Google Scholar]
  57. KhattabM.M. TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: A key role for superoxide anion.Eur. J. Pharmacol.20065481-316717310.1016/j.ejphar.2006.08.007 16973155
     [Google Scholar]
  58. SharmaG. BadruddeenB. AkhtarJ. KhanM.I. AhmadM. NeopaneD. Target receptors in diabetic neuropathy: Key insights & implications.Biomed. Res. Ther.20241186698671910.15419/bmrat.v11i8.914
     [Google Scholar]
  59. NabaviS.M. RahimnejadM. Asadi ArdebiliA. HajikhaniR. The role of Cannabinoid receptors in visceral pain sensation of rat: An interventional study.Journal of Lab Animal Research2024311510.58803/jlar.v3i1.38
     [Google Scholar]
  60. PénzesZ. HorváthD. MolnárP. Anandamide modulation of monocyte-derived Langerhans cells: Implications for immune homeostasis and skin inflammation.Front. Immunol.202415142377610.3389/fimmu.2024.1423776 38979427
     [Google Scholar]
  61. CarrascosaA.J. García-GutiérrezM.S. SaldañaR. ManzanaresJ. Additive antinociceptive action of intrathecal anandamide reuptake inhibitor and morphine in the management of post-incisional pain in rats.Biomed. Pharmacother.202417711705410.1016/j.biopha.2024.117054 38943991
     [Google Scholar]
  62. DasA. BalakrishnanP. Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain.Inflammopharmacology202533112113310.1007/s10787‑024‑01623‑8 39714723
     [Google Scholar]
  63. BäckrydE. ThemistocleousA. StenssonN. Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: Results from the pain in neuropathy study.Pain2024165122523210.1097/j.pain.0000000000003015 37578507
     [Google Scholar]
  64. KowalczykK. LasekP. TrąbkaN. Medical cannabis: Mechanisms of action and therapeutic targets.J. Educ. Health Sport20245817619010.12775/JEHS.2024.58.013
     [Google Scholar]
  65. ZhuC. LanX. WeiZ. YuJ. ZhangJ. Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain.Acta Pharm. Sin. B2024141678610.1016/j.apsb.2023.07.020 38239234
     [Google Scholar]
  66. SarkarS. BhuiU. KumarB. AshiqueS. KumarP. SharmaH. Correlation between cognitive impairment and peripheral biomarkers - significance of phosphorylated tau and amyloid-β in alzheimer’s disease: a new insight.Current Psychiatry Research and Reviews2024125
     [Google Scholar]
  67. SharmaH. PathakR. JainS. Ficus racemosa L: A review on its important medicinal uses, phytochemicals and biological activities.J. Popul. Ther. Clin. Pharmacol.2023301721322710.47750/jptcp.2023.30.17.018
     [Google Scholar]
  68. InamdarA. GurupadayyaB. HalagaliP. TippavajhalaV.K. KhanF. PathakR. Unraveling neurological drug delivery: Polymeric nanocarriers for enhanced blood-brain barrier penetration.Current Drug Targets202426124
     [Google Scholar]
  69. ChandraP. SharmaH. Phosphodiesterase inhibitors for treatment of Alzheimer’s Disease.Indian Drugs2024610772210.53879/id.61.07.14382
     [Google Scholar]
  70. PathakR. SharmaS. BhandariM. Neuroinflammation at the crossroads of metabolic and neurodegenerative diseases: Causes, consequences and interventions.J. Exp. Zool. India202421224472461
     [Google Scholar]
/content/journals/cnr/10.2174/0115672026391315250822063941
Loading
Anandamide as a Therapeutic Target for Alleviating Neuropathic Pain and Inflammation in Rat Models
Curr Neurovasc Res 22, 167 (2025); https://doi.org/10.2174/0115672026391315250822063941
/content/journals/cnr/10.2174/0115672026391315250822063941
/content/journals/cnr/10.2174/0115672026391315250822063941
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Anandamide; carrageenan; chronic constriction injury; endocannabinoid; inflammation; neuropathic pain

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test